Xylazine (“Tranq”) and Fentanyl: What Families Need to Know

Xylazine, widely known in harm reduction circles as “tranq,” is a veterinary sedative that has become increasingly common in the illicit drug supply, almost always mixed with fentanyl. It is not a new drug, but its presence in the fentanyl supply is a recent development with serious implications for overdose response, wound care, and treatment.

If someone you love uses or is at risk of using illicit opioids, understanding xylazine is no longer optional. Tranq changes how overdoses present, it does not respond to naloxone, and it causes severe wounds that can lead to amputation if untreated. This guide explains what families need to know clearly and practically.

What Families Should Understand About Xylazine

• Xylazine is not an opioid and cannot be reversed by naloxone
• It is used as an adulterant in fentanyl to extend the drug’s effects
• Xylazine causes a much deeper sedation than fentanyl alone
• Characteristic wounds appear at injection sites and can spread rapidly
• Naloxone should still be used in xylazine-fentanyl overdoses because it reverses the fentanyl component
• The DEA has confirmed xylazine-fentanyl in the drug supply in all 50 US states

What Is Xylazine?

Xylazine is an alpha-2 adrenergic agonist approved for use in veterinary medicine as a sedative and muscle relaxant. It is used in large animals, particularly horses and cattle, for surgical procedures. It has never been approved for human use, in any dose, for any purpose.

When combined with fentanyl, xylazine extends and deepens the sedation that fentanyl produces. Drug suppliers add it to fentanyl for this reason: it makes the drug feel stronger and last longer, which increases its appeal in the illicit market. The problem is that xylazine’s effects cannot be reversed by naloxone, which means standard overdose response is only partly effective when xylazine is present.

How Xylazine Changes an Overdose

In a standard fentanyl overdose, the biggest danger is respiratory depression. Fentanyl suppresses breathing. When you give naloxone, it reverses the fentanyl and the person begins breathing again.

Xylazine causes a different kind of sedation through a non-opioid mechanism. It creates a deep, unconscious state that naloxone cannot touch. So when someone overdoses on fentanyl that contains xylazine, naloxone reverses the fentanyl component and may restore some breathing, but the person often remains deeply sedated and may not fully regain consciousness as quickly as expected.

This does not mean naloxone is useless in a tranq-fentanyl overdose. It still reverses the fentanyl and reduces respiratory suppression. But it means that even after successful naloxone administration, the person may remain unconscious for an extended period and require emergency medical care to monitor and support breathing.

“Naloxone will not reverse the xylazine component of an overdose, but it should still be administered because it reverses the opioid component and can restore breathing. Always call 911.” — CDC Overdose Response Strategy, 2023

The Wound Problem: Tranq Wounds Are Different

The most distinctive and devastating effect of xylazine use, beyond the overdose risk, is the severe skin wounds it causes. These wounds appear at injection sites but are not limited to injection sites. In some cases, necrotic wounds appear on parts of the body far from where the drug was injected, which suggests a systemic vascular effect rather than purely local tissue damage.

Xylazine causes blood vessels to constrict severely. This reduces blood flow to tissue, causing it to die. The resulting wounds are open, necrotic sores that can spread rapidly and become infected with bacteria including antibiotic-resistant strains. Left untreated, they can progress to the point of requiring amputation.

People who use tranq-fentanyl often continue using despite open wounds because the drug prevents them from feeling pain at the site. The damage accumulates without the normal pain signals that would prompt someone to seek care. By the time wounds come to medical attention, they are often deep and serious.

Signs of Xylazine Wounds

• Open sores that do not heal, particularly on the arms, legs, and ankles
• Dark, blackened, or gray tissue at wound edges indicating necrosis
• Wounds that appear far from injection sites
• Swelling and warmth around wounds indicating infection
• Rapidly expanding wound size

If someone you know has wounds like these, they need medical attention urgently. Many hospital emergency departments and harm reduction organizations are now trained to treat xylazine wounds specifically. Ask specifically about wound care services when contacting a provider.

How to Identify Xylazine in the Supply

Unlike fentanyl, there are no currently widely available consumer-grade test strips for xylazine. Some harm reduction organizations are beginning to distribute xylazine test strips, but they are not as available as fentanyl strips. A sample that tests positive for fentanyl should be assumed to potentially contain xylazine, particularly in regions where tranq is known to be present in the supply.

The DEA reported in 2023 that xylazine-fentanyl was detected in all 50 states. Prevalence varies significantly by region. The Northeast, particularly Philadelphia, has been heavily affected, but xylazine has spread to mid-Atlantic states, the South, and major West Coast cities.

What Families Can Do

Have Naloxone and Know Overdose Response

Because naloxone reverses the fentanyl in a tranq-fentanyl combination, it is still essential. Always administer naloxone in a suspected overdose, call 911, and be prepared to keep the person in the recovery position and monitor their breathing even after administering naloxone. They may not wake up as quickly as in a fentanyl-only overdose.

Watch for Skin Changes

If you have a loved one who injects drugs, gently ask about their skin. Wounds that are not healing, particularly dark-edged sores on limbs, warrant immediate medical evaluation. Many people are embarrassed to seek care for wounds. Encouragement from family can make the difference between keeping a limb and losing it.

Understand That Standard Detox Protocols May Need Adjustment

Xylazine itself can cause withdrawal symptoms including agitation and hypertension that are distinct from opioid withdrawal. There is no FDA-approved treatment for xylazine withdrawal. Clinicians are developing protocols for managing it, which often involve addressing both the opioid withdrawal component with buprenorphine or methadone and the xylazine-specific symptoms with medications that stabilize blood pressure and agitation.

If your loved one is seeking treatment and has been using tranq-fentanyl, tell the treatment program. The information helps them plan appropriate care.

Look for Harm Reduction Programs That Address Xylazine

Many harm reduction programs have updated their services in response to xylazine. This includes specialized wound care (sometimes called “wound care drop-ins”), distribution of wound dressings, naloxone with education specific to tranq overdoses, and services to help connect people to treatment.

• Next Distro (nextdistro.org): Distributes supplies by mail in many states
• SAMHSA Treatment Locator: Helps find local treatment and harm reduction programs
• National Alliance of State Pharmacy Associations: Lists pharmacies offering naloxone by state

Talking to a Loved One About Tranq

If your loved one is using illicit opioids, they may not know that what they are using contains xylazine. The name “fentanyl” is in the news constantly. Many people using the drug are unaware of adulterants like tranq or the specific risks they create.

A non-judgmental conversation focused on safety, not shame, is more likely to be heard. You might say: “I’ve been reading about something called xylazine that’s showing up in the drug supply and it causes wounds that can get really serious. I just want to make sure you know what to look for.” That is a conversation about information, not an ultimatum. It may open a door.

A Rapidly Changing Situation

The xylazine situation is evolving quickly. Researchers, public health officials, and harm reduction workers are learning new information about its effects, prevalence, and best practices for wound care and withdrawal management on an ongoing basis. What is true in 2024 may be updated by 2025 as more data becomes available.

What does not change is the basic response: naloxone, call 911, watch for wounds, and encourage treatment when the person is ready. These remain the most important things a family can do.